Hemo Organic Ltd.
Snapshot View

14.10 -0.25 ▼-1.7%

06 December 2022, 04:01:00 PM
Volume: 1,596

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.hemoorganicltd.com
Market Cap 4.89 Cr.
Enterprise Value(EV) 4.92 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -0.18 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-03
Industry PE 35.17 Trailing Twelve Months Ending 2022-03
Book Value / Share 0.00 Trailing Twelve Months Ending 2022-03
Price to Book Value 10,846.15 Calculated using Price: 14.10
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.35 Cr. 3,465,900 Shares
FaceValue 10
Company Profile
Dinesh Allorga incorporated as public limited Company in August 1992. It is engaged in production and sale of ayurvedic medicines and chemicals.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.74%
1 Week
-8.74%
1 Month
-17.30%
3 Month
-48.26%
6 Month
-75.86%
1 Year
+93.15%
2 Year
-11.88%
5 Year
-1.74%
10 Year
+11.20%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 2.48 -7.77 -99.33 -19.17 -44.90 -61.38 -17.52 -53.35 -180.16
Return on Capital Employed (%) 3.35 -7.51 -96.61 -19.17 -39.88 -43.09 -11.35 -44.09 -89.20
Return on Assets (%) 2.31 -7.67 -101.27 -11.32 -15.99 -14.38 -4.75 -47.99 -65.16

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 1 1 0 0 0 0 0 0
Non Curr. Liab. 0 0 0 0 0 0 0 0 0 0
Curr. Liab. 0 0 0 1 1 1 0 0 0 0
Minority Int.
Equity & Liab. 2 1 0 1 1 1 0 0 0 0
Non Curr. Assets 1 1 0 0
Curr. Assets 0 0 0 1 1 1 0 0 0 0
Misc. Exp. not W/O
Total Assets 2 1 0 1 1 1 0 0 0 0

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 1 0 0 1 0 0 0 0 0 0
Other Income 0
Total Income 1 0 0 1 0 0 0 0 0 0
Total Expenditure -1 0 0 -1 0 0 0 0 0 0
PBIDT 0 0 0 0 0 0 0 0 0 0
Interest 0
Depreciation 0 0 0
Taxation
Exceptional Items 0 -1
PAT 0 0 -1 0 0 0 0 0 0 0
Adjusted EPS 0 0 -2 0 0 0 0 0 0 0

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 -1 0 0 0 0 0
Cash Fr. Inv. 0 0 1 0 0 0
Cash Fr. Finan. 0 0 0 0
Net Change 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 16.85 16.85 16.85 16.85 16.85 16.85 16.85 16.85 16.85
Public 83.15 83.15 83.15 83.15 83.15 83.15 83.15 83.15 83.15
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 28 Nov 2022
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Hetal Yogesh Patel & PACs
Mon, 14 Nov 2022
Board Meeting Outcome for Outcome Of Board Meeting Held On November 14 2022
we hereby inform you that the Board of Directors of the Company in their Board Meeting held on today i.e. on November 14 2022 at the Registered Office of the Company which was commenced at 05:00 P.M. and concluded at 05:30 P.M. have apart from other businesses considered approved and taken on record the Unaudited Standalone Financial Results of the Company for the quarter ended on September 30 2022 along with Limited Review Reports
Mon, 14 Nov 2022
Result- Financial Result For The Quarter Ended On September 30 2022
In reference to captioned subject and pursuant to Regulation 33(3) (d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are hereby submitting the followings: 1. Unaudited Standalone Financial Results for the quarter ended on September 30 2022;2. Limited Review Report;

Technical Scans View Details >>

Tue, 06 Dec 2022
Close Crossing Last Month Low Close Crossing Last Month Low
Opening at High Opening at High
Opening at Low Opening at Low
Opening at High for 3 days Opening at High for 3 days
Closing Below Previous Low Closing Below Previous Low

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 248,331.17 1,035.00 -0.2%
Cipla Ltd. 89,552.87 1,109.60 -0.5%
Divi's Laboratories Ltd. 89,088.60 3,355.90 -0.4%
Dr. Reddy's Laboratories Ltd. 72,830.48 4,374.20 -2.4%
Apollo Hospitals Enterprise Ltd. 68,844.81 4,788.05 +0.2%
Torrent Pharmaceuticals Ltd. 54,679.25 1,615.60 -0.2%
Abbott India Ltd. 42,939.85 20,207.65 +0.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.50 1,035.00 -0.2%
Cipla Ltd. Consolidated 2022-09 34.92 1,109.60 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-09 29.79 3,355.90 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 23.42 4,374.20 -2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 82.18 4,788.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 68.61 1,615.60 -0.2%
Abbott India Ltd. Standalone 2022-09 48.70 20,207.65 +0.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.68 1,035.00 -0.2%
Cipla Ltd. Consolidated 2022-09 4.09 1,109.60 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-09 7.35 3,355.90 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.51 4,374.20 -2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.53 4,788.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 8.98 1,615.60 -0.2%
Abbott India Ltd. Standalone 2022-09 15.82 20,207.65 +0.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 1,035.00 -0.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,109.60 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,355.90 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,374.20 -2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,788.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,615.60 -0.2%
Abbott India Ltd. Standalone 2022-03 0.00 20,207.65 +0.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,035.00 -0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,109.60 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,355.90 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,374.20 -2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,788.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,615.60 -0.2%
Abbott India Ltd. Standalone 2022-03 29.95 20,207.65 +0.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,035.00 -0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,109.60 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,355.90 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,374.20 -2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,788.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,615.60 -0.2%
Abbott India Ltd. Standalone 2022-03 29.95 20,207.65 +0.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,035.00 -0.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,109.60 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,355.90 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,374.20 -2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,788.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,615.60 -0.2%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,207.65 +0.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,035.00 -0.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,109.60 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,355.90 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,374.20 -2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,788.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,615.60 -0.2%
Abbott India Ltd. Standalone 2022-03 798.70 20,207.65 +0.7%

FAQ's On Hemo Organic Ltd.

What is Hemo Organic share price?

Can I buy Hemo Organic shares now?

What is the Market Cap of Hemo Organic?

What are the key metrics to analyse Hemo Organic?

What is the 52 Week High and Low of Hemo Organic?

What is the trend of Hemo Organic share price?